You could try looking for the American Society of Nephrology Kidney Week 2016 if you haven't done so already. The abstract was presented on the Saturday under the High-Impact Clinical Trials classification.
I doubt whether there is much more information available thus far in the public domain.
Dimerix vs Retrophin, page-39
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.5¢ | 38.0¢ | $444.0K | 1.151M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 7392 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |